[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334686-105":59,"doc-detail-334686-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tdf-and-taf-inhibit-liver-cancer-cell-migration-invasion-via-p7tp3","TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3","","Tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide fumarate (TAF) were investigated for their effects on malignant behaviors of liver cancer cells, compared with entecavir (ETV). Wound-healing, transwell, Matrigel transwell, and CCK-8 assays showed that TDF/TAF suppressed migration, invasion, and proliferation in HepG2 and Huh7 cells. Mechanistic analyses indicated reduced Wnt/β-catenin signaling activity and a marked increase of the tumor suppressor p7TP3, whereas ETV produced no significant changes. The findings support TDF/TAF as a promising therapeutic strategy via Wnt/β-catenin–mediated upregulation of p7TP3.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tdf-and-taf-inhibit-liver-cancer-cell-migration-invasion-via-p7tp3/334686/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tdf-and-taf-inhibit-liver-cancer-cell-migration-invasion-via-p7tp3/334686.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To investigate the roles and mechanisms of TDF, TAF, and entecavir (ETV) in malignant characteristics of liver cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do TDF/TAF affect liver cancer cell behavior in vitro?",{"text":117,"@type":113},"TDF/TAF inhibit migration, invasion, and proliferation of HepG2 and Huh7 cells, based on wound-healing, transwell, Matrigel transwell, and CCK-8 assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links TDF/TAF to the suppression of malignancy?",{"text":121,"@type":113},"TDF/TAF lower Wnt/β-catenin signaling activity and significantly increase the tumor suppressor p7TP3 in HepG2 and Huh7 cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334686,1790472060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTDF and TAF inhibit liver cancer cell migration, invasion via p7TP3  \nJing Zhao1,2, Li Zhou2,3, Yang Zhang2, Jun Cheng2, Yilan Zeng4 & Xiuling Li1*  \nTenofovir disoproxil fumarate (TDF) seems to prevent hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV). However, the mechanism is still little known. This study aimed to investigate the the roles and mechanisms ofTDF, tenofovir alafenamide fumarate (TAF), andentecavir (ETV) on the malignant characteristics of liver cancer cells. Using the wound-healing assays, transwell assays, matrigel transwell assays, and cell counting kit-8 (CCK-8) assays, it was possible to identify that TDF/TAF, inhibited migration, invasion, and proliferation of HepG2 cells and Huh7 cells. To investigate the mechanisms, we performed TOP/FOP-Flash system, Western blot, and RT-qPCRassays of liver cancer cells cultured with TDF/TAF and found a lower activity ofWnt/β-catenin signaling pathway compared with control cells. Finally, Hepatitis C virus p7 trans-regulated protein 3 (p7TP3), a tumor suppressor in liver cancers, was significantly increased in HepG2 cells and Huh7 cells that treated with TDF/TAF. However, entecavir (ETV)-treated liver cancer cells showed no significant difference in the malignant characteristics of liver cancer cells, activity ofWnt/β-catenin signaling pathway, and expression of p7TP3, compared with the control groups. To conclude, TDF/TAF maybe novel promising therapeutic strategy for liver cancers, including HCC and hepatoblastoma, via Wnt/β -catenin signaling pathway, by up-regulating expression of the tumor suppressor, p7TP3 .  \nKeywords TDF/TAF, Liver cancers, p7TP3, Wnt/β-catenin  \nHepatocellular carcinoma (HCC), one of the most prevalent and deadliest cancers, has limited treatment options and poor patient prognosis1. The five-year survival rate of localized HCC is 31% and falls to 2% for metastatic HCC2. To prolong the length of life and improve its quality, the present article aims to contribute to the development of cancer research field and design of novel therapy approach.  \nTenofovir disoproxil fumarate (TDF) and the newer Tenofovir alafenamide (TAF) are both pharmaceutical forms of tenofovir3. As nucleotide reverse transcriptase inhibitors, TDF and TAF are widely used for effective treatment of acquired human immunodeficiency virus and hepatitis B virus (HBV) infection in worldwide clinical settings4. Recent evidences suggest that TDF decrease the risk of HCC in patients with HBV5,6, reduce the HCC recurrence7, and lower the incidence of HCC in HIV/HBV-coinfected patients8. However, little is reported about the mechanisms ofTDF in HCC. Besides, our previous researches have reported that TDF/TAF prevented progression and promoted reversion of liver fibrosis and pulmonary fibrosis9, 10. Also, TDF/TAF inhibit inflammation in liver fibrosis9. In TDF-treated C57BL/6J mice, the differentially expressed genes (DEGs) were involved mainly in “immunity,” “inflammation,” and “metabolism” processes, comparing with control group11. Based on these studies, we suspect that TDF/TAF prevent progression of HCC, independently of its antiviral activity.  \nPrevious research findings between the first-line agents for the treatment of chronic Hepatitis B (CHB) and HCC occurrences have been inconsistent and contradictory. Dates from South Korean national cohort5, 12 and China national cohort13 demonstrate that TDF may confer a higher degree of protection from HCC, compared with entecavir (ETV). On the other hand, a 6-countries or regions cohort14 and another South Korean national cohort15 suggest that ETV and TDF show a comparable long-term risk of HCC. The roles of ETV, TDF, and TAFon clinical outcomes in CHB patients are controversial. At the same time, in this debate, there is a lack of voice for molecular biological mechanism researches. This paper attempts to show the discrepancies ","cbCairZbHEsPPnop","https://ap.wps.com/l/cbCairZbHEsPPnop","pdf",3993086,11,"English","# Background\n# Experimental approach\n## Cell assays\n## Mechanistic assays\n# Results\n## Effects of TDF/TAF on malignant phenotypes\n## Wnt/β-catenin signaling and p7TP3 regulation\n## Comparison with entecavir\n# Conclusion","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To investigate the roles and mechanisms of TDF, TAF, and entecavir (ETV) in malignant characteristics of liver cancer cells.\"},{\"question\":\"How do TDF/TAF affect liver cancer cell behavior in vitro?\",\"answer\":\"TDF/TAF inhibit migration, invasion, and proliferation of HepG2 and Huh7 cells, based on wound-healing, transwell, Matrigel transwell, and CCK-8 assays.\"},{\"question\":\"What mechanism links TDF/TAF to the suppression of malignancy?\",\"answer\":\"TDF/TAF lower Wnt/β-catenin signaling activity and significantly increase the tumor suppressor p7TP3 in HepG2 and Huh7 cells.\"}]","TDF and TAF inhibit liver cancer cell migration, invasion via p7TP3 | PDF",1790007857,28]